TABLE 3.
Prevalence of the four markers (p23, p54, p138, and p72) in various EBV serological groups determined with the EBV IgM/IgG Blot 3.0 kit and IF assaya
| Panel (n) and intensity | % IgG reaction to antigen
|
% IgM reaction to antigen
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VCA
|
EA
|
EBNA
|
VCA
|
EA
|
|||||||
| p23 | IF | p54 | p138 | IF | p72 | IF | p23 | IF | p54 | p138 | |
| A (78) | |||||||||||
| Normal | 0 | 0 | 0 | 0 | NT | 0 | 0 | 2.5 | 0 | 6.4 | 30.7 |
| ≥3+ | 0 | 0 | |||||||||
| B (26) | |||||||||||
| Normal | 100 | 100 | 30.7 | 23.0 | 29.6 | 100 | 100 | 0 | 0 | 7.6 | 26.9 |
| ≥3+ | 0 | 0 | |||||||||
| C (14) | |||||||||||
| Normal | 100 | 100 | 64.2 | 64.2 | 78.5 | 78.5 | 85.7 | 64.2 | 0 | 35.7 | 0 |
| ≥3+ | 85.7 | 35.7 | |||||||||
| D (37) | |||||||||||
| Normal | 51.4 | 94.5 | 78.3 | 72.9 | NT | 0 | 2.7 | 75.6 | 100 | 72.9 | 100 |
| ≥3+ | 0 | 0 | |||||||||
| E (21) | |||||||||||
| Normal | 80.9 | 80.9 | 4.7 | 9.5 | NT | 66.6 | 66.6 | 9.5 | 4.7 | 23.8 | 33.3 |
| ≥3+ | 0 | 0 | |||||||||
| F (47) | |||||||||||
| Normal | 97.8 | 97.8 | 31.9 | 25.5 | NT | 80.8 | 87.2 | 21.7 | ≤2.1 | 6.5 | 13.0 |
| ≥3+ | |||||||||||
| G (34) | |||||||||||
| Normal | 100 | 97 | 44.1 | 11.7 | NT | 20.5 | 2.9 | 29.4 | 0 | 17.6 | 17.6 |
| ≥3+ | 41.1 | 2.9 | 0 | ||||||||
a
In this study, we never detected anti-EBNA IgM, irrespective of panel. NT, not tested.